Neurol. praxi. 2020;21(2):114-119 | DOI: 10.36290/neu.2020.058

Management of respiratory muscleweakness in advanced stages of Duchenne muscular dystrophy

doc. MUDr. David Kemlink, Ph.D.
Neurologická klinika a Centrum klinických neurověd, 1. LF UK a VFN v Praze

Duchenne muscular dystrophy is a progressive neuromuscular disorder inevitably leading to respiratory muscle weakness with subsequent impaired airway clearance and hypercapnic respiratory failure. These complications were the main cause of death in this patient population. The main intervention is early and regular assessments of respiratory muscle strength and adequate compensation of the impartment. Thanks to modern technical devices it is possible to prolong the survival of the patients with preserved quality of life relative to the state before respiratory failure. The main methods are airway clearance techniques including regular use of mechanical insuflator - exsuflator (cough assistance) and non-invasive ventilation. The latter in more advanced stages of the disease requires providing the patient with multiple interfaces including the mouth-piece (or straw), and advanced life - support ventilators providing also volume controlled modes.

Keywords: Duchenne muscle dystrophy, noninvasive ventilation, airway clearance techniques, mouth-piece ventilation.

Published: June 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kemlink D. Management of respiratory muscleweakness in advanced stages of Duchenne muscular dystrophy. Neurol. praxi. 2020;21(2):114-119. doi: 10.36290/neu.2020.058.
Download citation

References

  1. Bach JR. Noninvasive Respiratory Management of Patients With Neuromuscular Disease. Ann Rehabil Med 2017; 41: 519-538. Go to original source... Go to PubMed...
  2. Bach JR, Goncalves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: a new management paradigm. Chest 2010; 137: 1033-1039. Go to original source... Go to PubMed...
  3. Barbe F, Quera-Salva MA, Mccann C, Gajdos P, Raphael JC, De Lattre J, Agusti AG. Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy. The European respiratory journal 1994; 7: 1403-1408. Go to original source... Go to PubMed...
  4. Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM, Group DMDCCW. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. The Lancet Neurology 2018a; 17: 347-361. Go to original source... Go to PubMed...
  5. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, Group DMDCCW. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurology 2018b; 17: 251-267. Go to original source... Go to PubMed...
  6. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, Mcdonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology 2010; 9: 77-93. Go to original source... Go to PubMed...
  7. Camela F, Gallucci M, Ricci G. Cough and airway clearance in Duchenne muscular dystrophy. Paediatric respiratory reviews 2019; 31: 35-39. Go to original source... Go to PubMed...
  8. Honnerová M, Kemlink D, Lněnička J, Šonka K, Vyskočilová J. Indikační kritéria pro domácí neinvazivní ventilační podporu (NIV). http://www.sleep-society.cz/images/odborne/doporucene-postupy/Indikace_NIV.pdf 2013; 2017.
  9. Hoque R. Sleep-Disordered Breathing in Duchenne Muscular Dystrophy: An Assessment of the Literature. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2016; 12: 905-911. Go to original source... Go to PubMed...
  10. Koessler W, Wanke T, Winkler G, Nader A, Toifl K, Kurz H, Zwick H. 2 Years' experience with inspiratory muscle training in patients with neuromuscular disorders. Chest 2001; 120: 765-769. Go to original source... Go to PubMed...
  11. Lomauro A, D'angelo MG, Aliverti A. Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Therapeutics and clinical risk management 2015; 11: 1475-1488. Go to original source... Go to PubMed...
  12. Neumannová K, Doušová T, Kos S, Sedlák V, Zatloukal J. Doporučený postup pro indikaci dlouhodobé domácí léčby pomocí CoughAssist. Česká pneumologická a ftizeologická společnost ve spolupráci s Českou společností dětské pneumologie 2017; www.pneumologie.cz/upload/1486744726.pdf.
  13. Rall S, Grimm T. Survival in Duchenne muscular dystrophy. Acta myologica: myopathies and cardiomyopathies: official journal of the Mediterranean Society of Myology/edited by the Gaetano Conte Academy for the study of striated muscle diseases 2012; 31: 117-120.
  14. Saito T, Ohfuji S, Matsumura T, Saito T, Maeda K, Maeda A, Fukushima W, Fujimura H, Sakoda S, Hirota Y. Safety of a Pandemic Influenza Vaccine and the Immune Response in Patients with Duchenne Muscular Dystrophy. Internal medicine (Tokyo, Japan) 2015; 54: 1199-1205. Go to original source... Go to PubMed...
  15. Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, Kravitz RM, Sawnani H, Shell R, Sussman MD, Wolfe LF. Respiratory Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics 2018; 142: S62-S71. Go to original source... Go to PubMed...
  16. Toussaint M, Chatwin M, Soudon P. Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience. Chronic respiratory disease 2007; 4: 167-177. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.